{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T17:06:49Z","timestamp":1792516009250,"version":"4.5.0"},"reference-count":95,"publisher":"MDPI AG","issue":"20","license":[{"start":{"date-parts":[[2023,10,11]],"date-time":"2023-10-11T00:00:00Z","timestamp":1696982400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cells"],"abstract":"<jats:p>Non-melanoma skin cancers (NMSCs) occur frequently in the Caucasian population and are considered a burden for health care. Risk factors include ultraviolet (UV) radiation, ethnicity and immunosuppression. The incidence of NMSC is significantly higher in solid organ transplant recipients (SOTRs) than in immunocompetent individuals, due to immunosuppressive medication use by SOTRs. While the immunosuppressive agents, calcineurin inhibitors and purine analogues increase the incidence of NMSC in transplant recipients, mTOR inhibitors do not. This is most likely due to the different immunological pathways that are inhibited by each class of drug. This review will focus on what is currently known about the immune response against cutaneous squamous cell carcinoma (cSCC) and basal cell carcinoma (BCC), two of the main types of NMSC. Furthermore, we will describe the different classes of immunosuppressants given to SOTRs, which part of the immune system they target and how they can contribute to NMSC development. The risk of developing NMSC in SOTRs is the result of a combination of inhibiting immunological pathways involved in immunosurveillance against NMSC and the direct (pro\/anti) tumor effects of immunosuppressants.<\/jats:p>","DOI":"10.3390\/cells12202441","type":"journal-article","created":{"date-parts":[[2023,10,12]],"date-time":"2023-10-12T03:07:47Z","timestamp":1697080067000},"page":"2441","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Immunity against Non-Melanoma Skin Cancer and the Effect of Immunosuppressive Medication on Non-Melanoma Skin Cancer Risk in Solid Organ Transplant Recipients"],"prefix":"10.3390","volume":"12","author":[{"given":"Dixie","family":"Bakker","sequence":"first","affiliation":[{"name":"Department of Dermatology, Netherlands Institute for Pigment Disorders, Amsterdam University Medical Centers, University of Amsterdam, 1105 AZ Amsterdam, The Netherlands"},{"name":"Cancer Center Amsterdam, Amsterdam Institute for Infection and Immunity, 1081 HV Amsterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walbert J.","family":"Bakker","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Netherlands Institute for Pigment Disorders, Amsterdam University Medical Centers, University of Amsterdam, 1105 AZ Amsterdam, The Netherlands"},{"name":"Cancer Center Amsterdam, Amsterdam Institute for Infection and Immunity, 1081 HV Amsterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcel W.","family":"Bekkenk","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Netherlands Institute for Pigment Disorders, Amsterdam University Medical Centers, University of Amsterdam, 1105 AZ Amsterdam, The Netherlands"},{"name":"Cancer Center Amsterdam, Amsterdam Institute for Infection and Immunity, 1081 HV Amsterdam, The Netherlands"},{"name":"Amsterdam University Medical Centers, VU University of Amsterdam, 1081 HV Amsterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0800-0721","authenticated-orcid":false,"given":"Rosalie M.","family":"Luiten","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Netherlands Institute for Pigment Disorders, Amsterdam University Medical Centers, University of Amsterdam, 1105 AZ Amsterdam, The Netherlands"},{"name":"Cancer Center Amsterdam, Amsterdam Institute for Infection and Immunity, 1081 HV Amsterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,10,11]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Cives, M., Mannavola, F., Lospalluti, L., Sergi, M.C., Cazzato, G., Filoni, E., Cavallo, F., Giudice, G., Stucci, L.S., and Porta, C. (2020). Non-Melanoma Skin Cancers: Biological and Clinical Features. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21155394"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1111\/ajt.13596","article-title":"Immunosuppressive Medications and Squamous Cell Skin Carcinoma: Nested Case-Control Study Within the Skin Cancer after Organ Transplant (SCOT) Cohort","volume":"16","author":"Coghill","year":"2016","journal-title":"Am. J. Transpl."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1177\/0956462415586316","article-title":"The risk of non-melanoma skin cancer in HIV-infected patients: New data and meta-analysis","volume":"27","author":"Zhao","year":"2016","journal-title":"Int. J. STD AIDS"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1097\/01.TP.0000184006.43152.8D","article-title":"Maintenance Immunosuppression with Target-of-Rapamycin Inhibitors is Associated with a Reduced Incidence of De Novo Malignancies","volume":"80","author":"Kauffman","year":"2005","journal-title":"Transplantation"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"624123","DOI":"10.1155\/2013\/624123","article-title":"Understanding Dendritic Cells and Their Role in Cutaneous Carcinoma and Cancer Immunotherapy","volume":"2013","author":"Yanofsky","year":"2013","journal-title":"Clin. Dev. Immunol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"661","DOI":"10.2165\/00044011-200525100-00005","article-title":"Treatment of Basal Cell Carcinoma Located in the Head and Neck Region with Intralesional Interferon \u03b1-2: Evaluation of Long-Term Follow-Up Results","volume":"25","author":"Bostanci","year":"2005","journal-title":"Clin. Drug Investig."},{"key":"ref_7","first-page":"116","article-title":"Intralesional interferon \u03b1-2b in the treatment of basal cell carcinoma and squamous cell carcinoma: Revisited","volume":"30","author":"Kim","year":"2004","journal-title":"Dermatol. Surg."},{"key":"ref_8","first-page":"2067","article-title":"Suppression of Type I Interferon Signaling Proteins Is an Early Event in Squamous Skin Carcinogenesis","volume":"8","author":"Clifford","year":"2002","journal-title":"Clin. Cancer Res."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.gendis.2014.08.005","article-title":"Ultraviolet radiation-induced non-melanoma skin cancer: Regulation of DNA damage repair and inflammation","volume":"1","author":"Kim","year":"2014","journal-title":"Genes Dis."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"2937","DOI":"10.4049\/jimmunol.1601681","article-title":"Anti-Inflammatory Role of Langerhans Cells and Apoptotic Keratinocytes in Ultraviolet-B-Induced Cutaneous Inflammation","volume":"199","author":"Hatakeyama","year":"2017","journal-title":"J. Immunol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"e1260215","DOI":"10.1080\/2162402X.2016.1260215","article-title":"Langerhans cells and NK cells cooperate in the inhibition of chemical skin carcinogenesis","volume":"6","author":"Ortner","year":"2017","journal-title":"Oncoimmunology"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1111\/j.0022-202X.2005.23904.x","article-title":"UVA radiation impairs phenotypic and functional maturation of human dermal dendritic cells","volume":"125","author":"Furio","year":"2005","journal-title":"J. Investig. Dermatol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.1038\/jid.2009.96","article-title":"Myeloid dendritic cells from human cutaneous squamous cell carcinoma are poor stimulators of T-cell proliferation","volume":"129","author":"Bluth","year":"2009","journal-title":"J. Investig. Dermatol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/978-3-030-36214-0_10","article-title":"Tumour Microenvironment in Skin Carcinogenesis","volume":"1226","author":"Georgescu","year":"2020","journal-title":"Adv. Exp. Med. Biol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"3330","DOI":"10.1200\/JCO.2008.19.9919","article-title":"Macrophage markers in serum and tumor have prognostic impact in American Joint Committee on Cancer stage I\/II melanoma","volume":"27","author":"Jensen","year":"2009","journal-title":"J. Clin. Oncol."},{"key":"ref_16","first-page":"425","article-title":"Macrophage infiltration and its prognostic implications in breast cancer: The relationship with VEGF expression and microvessel density","volume":"14","author":"Tsutsui","year":"2005","journal-title":"Oncol. Rep."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Chen, Y., Song, Y., Du, W., Gong, L., Chang, H., and Zou, Z. (2019). Tumor-associated macrophages: An accomplice in solid tumor progression. J. Biomed. Sci., 26.","DOI":"10.1186\/s12929-019-0568-z"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1038\/jid.2011.9","article-title":"Tumor-associated macrophages in the cutaneous SCC microenvironment are heterogeneously activated","volume":"131","author":"Pettersen","year":"2011","journal-title":"J. Investig. Dermatol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1038\/jid.2010.266","article-title":"The human cutaneous squamous cell carcinoma microenvironment is characterized by increased lymphatic density and enhanced expression of macrophage-derived VEGF-C","volume":"131","author":"Moussai","year":"2011","journal-title":"J. Investig. Dermatol."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Dollinger, E., Bergman, D., Zhou, P., Atwood, S.X., and Nie, Q. (2020). Divergent Resistance Mechanisms to Immunotherapy Explain Responses in Different Skin Cancers. Cancers, 12.","DOI":"10.1101\/2020.09.15.298182"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1084873","DOI":"10.3389\/fimmu.2023.1084873","article-title":"Understanding the squamous cell carcinoma immune microenvironment","volume":"14","author":"Saeidi","year":"2023","journal-title":"Front. Immunol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1042\/CS20180845","article-title":"Genomic testing, tumor microenvironment and targeted therapy of Hedgehog-related human cancers","volume":"133","author":"Katoh","year":"2019","journal-title":"Clin. Sci."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1158\/1078-0432.CCR-13-2508","article-title":"Myeloid-derived suppressor cells predict survival of patients with advanced melanoma: Comparison with regulatory T cells and NY-ESO-1- or melan-A-specific T cells","volume":"20","author":"Weide","year":"2014","journal-title":"Clin. Cancer Res."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"4096","DOI":"10.1158\/1078-0432.CCR-14-0635","article-title":"Inhibition of tumor-derived prostaglandin-e2 blocks the induction of myeloid-derived suppressor cells and recovers natural killer cell activity","volume":"20","author":"Mao","year":"2014","journal-title":"Clin. Cancer Res."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1158\/0008-5472.CAN-09-1882","article-title":"Immune stimulatory receptor CD40 is required for T-cell suppression and T regulatory cell activation mediated by myeloid-derived suppressor cells in cancer","volume":"70","author":"Pan","year":"2010","journal-title":"Cancer Res."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"107996","DOI":"10.1016\/j.intimp.2021.107996","article-title":"Regulatory role of methionine enkephalin in myeloid-derived suppressor cells and macrophages in human cutaneous squamous cell carcinoma","volume":"99","author":"Bai","year":"2021","journal-title":"Int. Immunopharmacol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.jdermsci.2016.04.013","article-title":"Cutaneous squamous cell carcinomas with markers of increased metastatic risk are associated with elevated numbers of neutrophils and\/or granulocytic myeloid derived suppressor cells","volume":"83","author":"Seddon","year":"2016","journal-title":"J. Dermatol. Sci."},{"key":"ref_28","first-page":"983698","article-title":"Neutrophils in Cancer: Two Sides of the Same Coin","volume":"2015","author":"Rosales","year":"2015","journal-title":"J. Immunol. Res."},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Khou, S., Popa, A., Luci, C., Bihl, F., Meghraoui-Kheddar, A., Bourdely, P., Salavagione, E., Cosson, E., Rubod, A., and Cazareth, J. (2020). Tumor-Associated Neutrophils Dampen Adaptive Immunity and Promote Cutaneous Squamous Cell Carcinoma Development. Cancers, 12.","DOI":"10.3390\/cancers12071860"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1084\/jem.187.12.2045","article-title":"Dermal mast cells determine susceptibility to ultraviolet B-induced systemic suppression of contact hypersensitivity responses in mice","volume":"187","author":"Hart","year":"1998","journal-title":"J. Exp. Med."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1046\/j.1523-1747.2000.00050.x","article-title":"Communications: High dermal mast cell prevalence is a predisposing factor for basal cell carcinoma in humans","volume":"115","author":"Grimbaldeston","year":"2000","journal-title":"J. Investig. Dermatol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1186\/s12943-020-01238-x","article-title":"Natural killer cells in cancer biology and therapy","volume":"19","author":"Wu","year":"2020","journal-title":"Mol. Cancer"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.it.2019.03.004","article-title":"Cancer Immunoediting by Innate Lymphoid Cells","volume":"40","author":"Wagner","year":"2019","journal-title":"Trends Immunol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1016\/j.jid.2021.03.018","article-title":"Cutaneous Squamous Cell Carcinoma Development Is Associated with a Temporal Infiltration of ILC1 and NK Cells with Immune Dysfunctions","volume":"141","author":"Luci","year":"2021","journal-title":"J. Investig. Dermatol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"30894","DOI":"10.18632\/oncotarget.25768","article-title":"ST2\/IL-33 signaling promotes malignant development of experimental squamous cell carcinoma by decreasing NK cells cytotoxicity and modulating the intratumoral cell infiltrate","volume":"9","author":"Gasparoto","year":"2018","journal-title":"Oncotarget"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1038\/ki.2015.237","article-title":"Peripheral natural killer cell and allo-stimulated T-cell function in kidney transplant recipients associate with cancer risk and immunosuppression-related complications","volume":"88","author":"Hope","year":"2015","journal-title":"Kidney Int."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1002\/JLB.5MR0920-198RR","article-title":"Mechanisms of NK cell dysfunction in the tumor microenvironment and current clinical approaches to harness NK cell potential for immunotherapy","volume":"109","author":"Devillier","year":"2021","journal-title":"J. Leukoc. Biol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1189\/jlb.4RU0114-001R","article-title":"Immunosuppressive roles of natural killer T (NKT) cells in the skin","volume":"96","author":"McKee","year":"2014","journal-title":"J. Leukoc. Biol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1126\/science.1063916","article-title":"Regulation of cutaneous malignancy by \u03b3\u03b4 T cells","volume":"294","author":"Girardi","year":"2001","journal-title":"Science"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.micinf.2009.02.004","article-title":"The biology of cytotoxic cell granule exocytosis pathway: Granzymes have evolved to induce cell death and inflammation","volume":"11","author":"Pardo","year":"2009","journal-title":"Microbes Infect."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1111\/j.1751-1097.2010.00859.x","article-title":"Differential roles of T-cell subsets in regulation of ultraviolet radiation induced cutaneous photocarcinogenesis","volume":"87","author":"Nasti","year":"2011","journal-title":"Photochem. Photobiol."},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Zeng, Z., Veitch, M., Kelly, G.A., Tuong, Z.K., Cruz, J.G., Frazer, I.H., and Wells, J.W. (2021). IFN-\u03b3 Critically Enables the Intratumoural Infiltration of CXCR3+ CD8+ T Cells to Drive Squamous Cell Carcinoma Regression. Cancers, 13.","DOI":"10.3390\/cancers13092131"},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Linedale, R., Schmidt, C., King, B.T., Ganko, A.G., Simpson, F., Panizza, B.J., and Leggatt, G.R. (2017). Elevated frequencies of CD8 T cells expressing PD-1, CTLA-4 and Tim-3 within tumour from perineural squamous cell carcinoma patients. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0175755"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1126\/science.aae0491","article-title":"The epigenetic landscape of T cell exhaustion","volume":"354","author":"Sen","year":"2016","journal-title":"Science"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1111\/ijd.15065","article-title":"Sparsity of dendritic cells and cytotoxic T cells in tumor microenvironment may lead to recurrence in basal cell carcinoma","volume":"59","author":"Erdem","year":"2020","journal-title":"Int. J. Dermatol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"4677","DOI":"10.1158\/1078-0432.CCR-22-1332","article-title":"High-Dimensional and Spatial Analysis Reveals Immune Landscape-Dependent Progression in Cutaneous Squamous Cell Carcinoma","volume":"28","author":"Ferguson","year":"2022","journal-title":"Clin. Cancer Res."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1097\/CJI.0b013e3181cc2615","article-title":"Immunosuppression affects CD4+ mRNA expression and induces Th2 dominance in the microenvironment of cutaneous squamous cell carcinoma in organ transplant recipients","volume":"33","author":"Kosmidis","year":"2010","journal-title":"J. Immunother."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1084\/jem.20150204","article-title":"A novel IL-17 signaling pathway controlling keratinocyte proliferation and tumorigenesis via the TRAF4-ERK5 axis","volume":"212","author":"Wu","year":"2015","journal-title":"J. Exp. Med."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1111\/php.12351","article-title":"Interleukin-17 mediated inflammatory responses are required for ultraviolet radiation-induced immune suppression","volume":"91","author":"Li","year":"2015","journal-title":"Photochem. Photobiol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1002\/eji.201847659","article-title":"Targeting Treg cells in cancer immunotherapy","volume":"49","author":"Tanaka","year":"2019","journal-title":"Eur. J. Immunol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"365","DOI":"10.4049\/jimmunol.179.1.365","article-title":"IL-10 controls ultraviolet-induced carcinogenesis in mice","volume":"179","author":"Loser","year":"2007","journal-title":"J. Immunol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1111\/bjd.13172","article-title":"Intense Foxp3+ CD25+ regulatory T-cell infiltration is associated with high-grade cutaneous squamous cell carcinoma and counterbalanced by CD8+\/Foxp3+ CD25+ ratio","volume":"172","author":"Azzimonti","year":"2015","journal-title":"Br. J. Dermatol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1038\/nature04808","article-title":"IL-23 promotes tumour incidence and growth","volume":"442","author":"Langowski","year":"2006","journal-title":"Nature"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.trecan.2016.10.010","article-title":"B lymphocytes and cancer: A love-hate relationship","volume":"2","author":"Yuen","year":"2016","journal-title":"Trends Cancer"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/s41568-019-0144-6","article-title":"Tertiary lymphoid structures in the era of cancer immunotherapy","volume":"19","author":"Petitprez","year":"2019","journal-title":"Nat. Rev. Cancer"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"981074","DOI":"10.3389\/fmed.2022.981074","article-title":"Tertiary lymphoid structures accompanied by fibrillary matrix morphology impact anti-tumor immunity in basal cell carcinomas","volume":"9","author":"Byers","year":"2022","journal-title":"Front. Med."},{"key":"ref_57","doi-asserted-by":"crossref","unstructured":"Thai, A.A., Young, R.J., Bressel, M., Angel, C., McDowell, L., Tiong, A., Bucknell, N.W., Fellowes, A., Xu, H., and Trigos, A. (2023). Comprehensive profiling identifies tumour and immune-microenvironmental differences in clinical subsets of cutaneous squamous cell carcinoma. Br. J. Dermatol.","DOI":"10.1093\/bjd\/ljad250"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.ccr.2005.04.014","article-title":"De novo carcinogenesis promoted by chronic inflammation is B lymphocyte dependent","volume":"7","author":"Korets","year":"2005","journal-title":"Cancer Cell"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"10662","DOI":"10.1073\/pnas.1100994108","article-title":"B regulatory cells and the tumor-promoting actions of TNF-\u03b1 during squamous carcinogenesis","volume":"108","author":"Schioppa","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1016\/j.jid.2019.12.018","article-title":"B Cell-Targeted Immunotherapy Limits Tumor Growth, Enhances Survival, and Prevents Lymph Node Metastasis of UV-Induced Keratinocyte Cancers in Mice","volume":"140","author":"Kok","year":"2020","journal-title":"J. Investig. Dermatol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1111\/j.1600-6143.2012.04292.x","article-title":"A surveillance model for skin cancer in organ transplant recipients: A 22-year prospective study in an ethnically diverse population","volume":"13","author":"Harwood","year":"2013","journal-title":"Am. J. Transpl."},{"key":"ref_62","first-page":"622","article-title":"Comparative epidemiology and pathogenic factors for nonmelanoma skin cancer in organ transplant patients","volume":"30","author":"Ulrich","year":"2004","journal-title":"Dermatol. Surg."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/jdv.16025","article-title":"Cutaneous squamous cell carcinoma (cSCC) and immunosurveillance\u2014The impact of immunosuppression on frequency of cSCC","volume":"33","author":"Plasmeijer","year":"2019","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1067\/mjd.2002.125579","article-title":"Skin cancer in organ transplant recipients: Epidemiology, pathogenesis, and management","volume":"47","author":"Berg","year":"2002","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"3951","DOI":"10.1182\/blood-2004-10-3927","article-title":"Cyclosporin A and tacrolimus, but not rapamycin, inhibit MHC-restricted antigen presentation pathways in dendritic cells","volume":"105","author":"Lee","year":"2005","journal-title":"Blood"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0162-3109(00)00192-2","article-title":"Mechanisms of action of cyclosporine","volume":"47","author":"Matsuda","year":"2000","journal-title":"Immunopharmacology"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"8483","DOI":"10.1073\/pnas.96.15.8483","article-title":"Development of gene-switch transgenic mice that inducibly express transforming growth factor beta1 in the epidermis","volume":"96","author":"Wang","year":"1999","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_68","first-page":"7435","article-title":"Inducible expression of transforming growth factor beta1 in papillomas causes rapid metastasis","volume":"61","author":"Weeks","year":"2001","journal-title":"Cancer Res."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1093\/abbs\/gmx127","article-title":"Paradoxical roles of TGF-\u03b2 signaling in suppressing and promoting squamous cell carcinoma","volume":"50","author":"Wu","year":"2018","journal-title":"Acta Biochim. Biophys. Sin."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"4405","DOI":"10.1158\/0008-5472.CAN-04-1032","article-title":"Overexpression of transforming growth factor beta1 in head and neck epithelia results in inflammation, angiogenesis, and epithelial hyperproliferation","volume":"64","author":"Lu","year":"2004","journal-title":"Cancer Res."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.bbmt.2010.08.014","article-title":"Mycophenolic acid inhibits natural killer cell proliferation and cytotoxic function: A possible disadvantage of including mycophenolate mofetil in the graft-versus-host disease prophylaxis regimen","volume":"17","author":"Ohata","year":"2011","journal-title":"Biol. Blood Marrow Transpl."},{"key":"ref_72","doi-asserted-by":"crossref","unstructured":"Zhang, S., Fujita, H., Mitsui, H., Yanofsky, V.R., Fuentes-Duculan, J., Pettersen, J.S., Su\u00e1rez-Fari\u00f1as, M., Gonzalez, J., Wang, C.Q., and Krueger, J.G. (2013). Increased Tc22 and Treg\/CD8 ratio contribute to aggressive growth of transplant associated squamous cell carcinoma. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0062154"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"e86434","DOI":"10.1172\/jci.insight.86434","article-title":"Cyclosporine A immunosuppression drives catastrophic squamous cell carcinoma through IL-22","volume":"1","author":"Abikhair","year":"2016","journal-title":"JCI Insight"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1038\/nature08996","article-title":"Opposing roles for calcineurin and ATF3 in squamous skin cancer","volume":"465","author":"Wu","year":"2010","journal-title":"Nature"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1038\/jid.2014.77","article-title":"The oncogene ATF3 is potentiated by cyclosporine A and ultraviolet light A","volume":"134","author":"Dziunycz","year":"2014","journal-title":"J. Investig. Dermatol."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1093\/ndt\/gfg594","article-title":"In vitro treatment of dendritic cells with tacrolimus: Impaired T-cell activation and IP-10 expression","volume":"19","author":"Tiefenthaler","year":"2004","journal-title":"Nephrol. Dial. Transpl."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1172\/JCI200318384","article-title":"Azathioprine: Old drug, new actions","volume":"111","author":"Maltzman","year":"2003","journal-title":"J. Clin. Investig."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1172\/JCI16432","article-title":"CD28-dependent Rac1 activation is the molecular target of azathioprine in primary human CD4+ T lymphocytes","volume":"111","author":"Tiede","year":"2003","journal-title":"J. Clin. Investig."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1126\/science.1114233","article-title":"Azathioprine and UVA light generate mutagenic oxidative DNA damage","volume":"309","author":"Perrett","year":"2005","journal-title":"Science"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"s2","DOI":"10.1191\/0961203305LU2109OA","article-title":"Mechanisms of action of mycophenolate mofetil","volume":"14","author":"Allison","year":"2005","journal-title":"Lupus"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"3919","DOI":"10.4049\/jimmunol.1000296","article-title":"A versatile role of mammalian target of rapamycin in human dendritic cell function and differentiation","volume":"185","author":"Haidinger","year":"2010","journal-title":"J. Immunol."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"e1479627","DOI":"10.1080\/2162402X.2018.1479627","article-title":"Clinically-Relevant Rapamycin Treatment Regimens Enhance CD8+ Effector Memory T Cell Function In The Skin and Allow their Infiltration into Cutaneous Squamous Cell Carcinoma","volume":"7","author":"Jung","year":"2018","journal-title":"Oncoimmunology"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"6436","DOI":"10.1038\/sj.onc.1209886","article-title":"mTOR and cancer therapy","volume":"25","author":"Easton","year":"2006","journal-title":"Oncogene"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1111\/exd.13079","article-title":"Effects of mammalian target of rapamycin inhibitors on cytokine production and differentiation in keratinocytes","volume":"25","author":"DeTemple","year":"2016","journal-title":"Exp. Dermatol."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1111\/j.0022-202X.2004.23426.x","article-title":"Loss of keratin 10 leads to mitogen-activated protein kinase (MAPK) activation, increased keratinocyte turnover, and decreased tumor formation in mice","volume":"123","author":"Reichelt","year":"2004","journal-title":"J. Investig. Dermatol."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1146\/annurev.me.37.020186.001243","article-title":"Action and toxicity of cyclosporine","volume":"37","author":"Bennett","year":"1986","journal-title":"Annu. Rev. Med."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1002\/eji.200535503","article-title":"IL-22 regulates the expression of genes responsible for antimicrobial defense, cellular differentiation, and mobility in keratinocytes: A potential role in psoriasis","volume":"36","author":"Wolk","year":"2006","journal-title":"Eur. J. Immunol."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1111\/j.1523-1747.2004.23440.x","article-title":"Cutaneous oncology in organ transplant recipients: Meeting the challenge of squamous cell carcinoma","volume":"123","author":"Carucci","year":"2004","journal-title":"J. Investig. Dermatol."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1124\/jpet.104.074815","article-title":"Selective inhibition of inflammatory gene expression in activated T lymphocytes: A mechanism of immune suppression by thiopurines","volume":"312","author":"Thomas","year":"2005","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1056\/NEJMoa1204166","article-title":"Sirolimus and secondary skin-cancer prevention in kidney transplantation","volume":"367","author":"Euvrard","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/nature08155","article-title":"mTOR regulates memory CD8 T-cell differentiation","volume":"460","author":"Araki","year":"2009","journal-title":"Nature"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1111\/j.1600-6143.2009.02997.x","article-title":"Switch to a sirolimus-based immunosuppression in long-term renal transplant recipients: Reduced rate of (pre-)malignancies and nonmelanoma skin cancer in a prospective, randomized, assessor-blinded, controlled clinical trial","volume":"10","author":"Salgo","year":"2010","journal-title":"Am. J. Transpl."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1182\/blood.V98.1.174","article-title":"Rapamycin induces apoptosis in monocyte- and CD34-derived dendritic cells but not in monocytes and macrophages","volume":"98","author":"Woltman","year":"2001","journal-title":"Blood"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1097\/01.TP.0000123082.31092.53","article-title":"Wound-healing complications after kidney transplantation: A prospective, randomized comparison of sirolimus and tacrolimus","volume":"77","author":"Dean","year":"2004","journal-title":"Transplantation"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"403280","DOI":"10.1155\/2013\/403280","article-title":"Systemic and nonrenal adverse effects occurring in renal transplant patients treated with mTOR inhibitors","volume":"2013","author":"Zaza","year":"2013","journal-title":"Clin. Dev. Immunol."}],"container-title":["Cells"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2073-4409\/12\/20\/2441\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T21:05:15Z","timestamp":1760130315000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2073-4409\/12\/20\/2441"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,11]]},"references-count":95,"journal-issue":{"issue":"20","published-online":{"date-parts":[[2023,10]]}},"alternative-id":["cells12202441"],"URL":"https:\/\/doi.org\/10.3390\/cells12202441","relation":{},"ISSN":["2073-4409"],"issn-type":[{"value":"2073-4409","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,11]]}}}